Innoviva Inc (INVA) - News Archive

Showing 3 of 3 results.

Innovivas Strategic Acquisition Pioneering the Path for Zevtera in the U.S. Antibiotic Market,

Innoviva Specialty Therapeutics Secures U.S. Marketing Rights for Zevtera in Strategic Agreement In a significant move that underscores the dynamism of the biopharmaceutical industry, Innoviva Specialty Therapeutics has...

Dec 16, 2024 Business Update Nasdaq

Innoviva Inc. Navigating Quarterly Gains Amid Year-to-Date Challenges in Biopharmaceutical Arena,

Innoviva Inc. Reports Third Quarter 2024 Financial Results: A Mixed Bag for Investors Innoviva Inc. (NASDAQ: INVA) has recently published its third quarter 2024 financial results, providing investors with a snapshot of...

Nov 7, 2024 • Major Pharmaceutical Preparations Industry Business Update NASDAQ

Innoviva Inc. Reports Third Quarter Financial Results with Promising Market Performance

This article aims to provide a summary of the recent financial results for Innoviva, Inc. (NASDAQ: INVA) for the third quarter of 2024, along with an analysis of the company s recent progress within the pharmaceutical s...

Nov 6, 2024 • Major Pharmaceutical Preparations Industry Business Update NASDAQ